Philips Launches IntraSight Plus Interventional Guidance Platform 

March 30, 2026—Royal Philips announced the launch of the IntraSight Plus interventional guidance platform, which has received FDA 510(k) clearance in the United States and CE Mark approval Europe.

According to the company, the redesigned IntraSight Plus platform merges Philips’ IntraSight and SyncVision technologies to combine class IA intravascular ultrasound and instantaneous wave-free ratio/fractional flow reserve physiology with coregistration, triregistration, and real-time device visualization. The company noted that the system is intended to streamline access to key interventional tools for clinicians to diagnosis, virtually plan treatment, guide device placement, and verify results on a single screen.

Philips stated that the first patient case using IntraSight Plus was recently performed by Professor Jan-Malte Sinning, MD, at Cellitinnen-Krankenhaus St. Vinzenz in Köln, Germany. The hospital’s catheterization lab infrastructure incorporates Philips’ Azurion interventional suites and has added IntraSight Plus to enhance physician workflow.

As described in the press release, Prof. Sinning performed a complete revascularization on a patient who presented with an acute ST-elevation myocardial infarction of the left anterior descending artery and underlying complex three-vessel disease.

The integrated triregistration of angiography, physiological assessment, and intravascular imaging allowed treatment to be focused on hemodynamically relevant lesions and ensured optimal stent deployment, noted the company.

“Modern PCI is becoming increasingly complex,” commented Prof. Sinning in Philips’ press release. “Intravascular imaging combined with physiology provides the level of detail we need for contemporary percutaneous coronary intervention. What stands out with IntraSight Plus is that the platform is clearly designed around how we actually work in the cath lab—combining physiology, imaging, and decision-making support in a way that fits naturally into the clinical workflow.”